The average one-year price target for Minerva Neurosciences was revised to $7.40, up 61.11% from the prior $4.59 estimate dated Feb 21, 2026. This consensus average of analyst targets indicates materially higher analyst optimism for the stock, though the brief article provides no accompanying operational or fundamental drivers.
The average one-year price target for Minerva Neurosciences was revised to $7.40, up 61.11% from the prior $4.59 estimate dated Feb 21, 2026. This consensus average of analyst targets indicates materially higher analyst optimism for the stock, though the brief article provides no accompanying operational or fundamental drivers.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
